Zelensky asks Merkel to assist in allocating COVID-19 vaccine to Ukraine

    The parties agreed to further coordinate efforts to overcome the consequences of the pandemic.

    President of Ukraine Volodymyr Zelensky on November 10 had a phone call with Germany's Chancellor Angela Merkel during which he asked the German leader to assist in supplying a U.S.-German-developed COVID-19 vaccine to Ukraine.

    "We welcome the breakthrough achieved by the German company BioNTech together with the American company Pfizer in the development of a coronavirus vaccine. This is very encouraging news. I would like to ask for your assistance in taking into account the interests of Ukraine when planning the supply of COVID-19 vaccine," Zelensky said, according to the press service of the Ukrainian President's Office.

    Pfizer vaccine

    • The product developed by Pfizer and BioNTech is 90% effective, the producer says. The Phase 3 clinical trial of BNT162b2 began on July 27 and has enrolled 43,538 participants to date, 38,955 of whom have received a second dose of the vaccine candidate as of November 8, 2020.
    • Approximately 42% of global participants and 30% of U.S. participants have racially and ethnically diverse backgrounds. The trial is continuing to enroll and is expected to continue through the final analysis when a total of 164 confirmed COVID-19 cases have accrued.
    • After discussion with the FDA, the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases. Upon the conclusion of those discussions, the evaluable case count reached 94 and the Data Monitoring Committee performed its first analysis on all cases. The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90%, at seven days after the second dose.
    • Pfizer says there are no serious side effects. If key indicators are safe, the world may have a tool to tackle the pandemic in a week.
    • The European Commission has already agreed to sign an agreement with the developers on the purchase of 300 million doses of the coronavirus vaccine.



    Source -  UNIAN


    #
    #POLITICS
    #SECURITY
    #DIPLOMACY
    #ZELINSKY

    11.11.2020 12:46





Latest news

    Georgia’s Constitutional Court Continues Case on Banning Opposition Parties: Political Pluralism at Stake

    12.Oct.2026

    Azerbaijan and Iran Step Up Security Contacts Amid Hijab Protests

    12.Oct.2026

    Personnel Shortages Complicate Ukrainian Forces’ Rotation: Ukraine Faces Long-Term Challenges on the Front Line

    11.Oct.2026

    Trump Eases Sanctions on Russian Fuel After Talks with Putin: Kyiv Fears Boost to Moscow’s War Revenues

    10.Oct.2026

    Putin Seeks to Strengthen Russia’s Influence in the Post-Soviet Space Through the CIS

    10.Oct.2026

    Russia and the South Caucasus: External Pressure, Political Competition and a Crisis of Trust

    10.Oct.2026

    Peaceful Settlement Between Armenia and Azerbaijan: Moving from Declarations to Implementation

    10.Oct.2026

    Moldova Ready to Accept as Many Ukrainians as Necessary if Situation Worsens This Winter

    09.Oct.2026

    Turkmenistan Turns Avaza into a Regional Diplomatic Hub as Caspian, Central Asian and CIS Agendas Converge

    08.Oct.2026

    Romania Scrambles Spanish F-18s After Aerial Targets Detected Near Ukrainian Border

    07.Oct.2026

    Berlin Deepens Defence Partnership with Kyiv: Germany to Provide Ukraine with €1 Billion in Military Aid

    07.Oct.2026

    European Parliament Against Georgian Dream: EU Prepares New Response to Tbilisi

    06.Oct.2026

    Bulgarian Foreign Minister to Discuss European Security and International Law in the Netherlands

    05.Oct.2026

    Rheinmetall in Bulgaria: Sofia Emerges as a New NATO Defence-Industrial Hub in the Balkans

    05.Oct.2026

    The Cost of a Long War: Moscow Expands Spending Plans Through 2029

    05.Oct.2026

All news